In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abiomed acquires Impella for cash and stock

Executive Summary

Abiomed (manufactures cardiovascular products) has agreed to acquire Impella CardioSystems (manufactures and markets blood pumps) for about 4mm common shares (valued at $43.8mm) and $1.8mm in cash, plus earn-outs that total up to $29mm (of which no more than $15mm will be paid in stock).
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Payment Includes Cash
    • Full Acquisition
    • Payment Includes Stock
    • Includes Contract

Related Companies

UsernamePublicRestriction

Register